Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Jean Schoenen
Introduction
Jean Schoenen is a notable inventor based in Beaufays-Chaudfontaine, Belgium. He has made significant contributions to the field of medicine, particularly in the treatment of migraines. His innovative approach has led to the development of a unique treatment method that utilizes specific compounds to alleviate migraine symptoms.
Latest Patents
Schoenen holds a patent for the treatment of migraine by administration of α-lipoic acid or its derivatives. This invention relates to the use of racemic α-lipoic acid or its enantiomers, as well as pharmaceutically acceptable salts, amides, esters, or thioesters in either reduced or oxidized form. The active ingredient is aimed at preventing or treating migraines, whether acute or chronic. He has 1 patent to his name, showcasing his innovative approach to addressing this common ailment.
Career Highlights
Jean Schoenen has had a distinguished career, working with Asta Medica, a well-respected company in the pharmaceutical industry. His work has focused on developing effective treatments that improve the quality of life for individuals suffering from migraines. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Throughout his career, Schoenen has collaborated with esteemed colleagues, including Jürgen Engel and Klaus Wessel. These partnerships have fostered an environment of innovation and have contributed to the advancement of migraine treatment methodologies.
Conclusion
Jean Schoenen's contributions to the field of migraine treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the medical community and offers hope to those affected by migraines.